Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RX PRO is a Brazilian healthtech company that provides a digital platform designed to connect pharmaceutical companies with healthcare professionals. The company specializes in "digital detailing," allowing pharmaceutical representatives to share scientific information and product updates with physicians through a remote, data-driven interface. By leveraging technology to optimize the traditional medical visitation model, RX PRO helps pharma companies increase their reach and engagement with doctors across various specialties. The platform offers tools for sample requests, medical education, and performance analytics to streamline the relationship between industry and prescribers. In 2022, the company was acquired by Eurofarma, a leading Brazilian pharmaceutical multinational, to enhance its digital transformation and physician relationship capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RX PRO Soluções de Tecnologia.